ArisGlobal Appraised at CMMI-DEV Level 3

Apr 12, 2018

Miami, Florida, April 12, 2018 –ArisGlobal, a leading provider of integrated cloud-based software solutions for life sciences, today announced that it has been independently appraised at Development (DEV) Level 3 of the CMMI Institute’s Capability Maturity Model Integration (CMMI)®. The appraisal was performed by SITARA technologies Pvt. Ltd.

CMMI® is a capability improvement approach that provides organizations with the essential elements of effective processes that ultimately improve their processes. An appraisal at Maturity Level 3 indicates the organization is performing at a “defined” level whereby processes are well characterized and understood, and are described in standards, procedures, tools, and methods. The organization’s set of standard processes, which is the basis for Maturity Level 3, is established and improved over time.

“Achieving CMMI-DEV Level 3 appraisal reflects ArisGlobal’s strong focus and commitment to improving the quality of our software solutions,” said Ashok Katti, Chief Operating Officer and President APAC, ArisGlobal. “Our customers can feel confident that we are continuously working to deliver the highest level of customer satisfaction and product quality.”  

 

About CMMI® Institute

CMMI Institute is the global leader in the advancement of best practices in people, process, and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and build maturity by comparing their operations to best practices and identifying performance gaps. For over 25 years, thousands of high-performing organizations in a variety of industries, including aerospace, finance, health services, software, defense, transportation, and telecommunications, have earned a CMMI maturity level rating and proved they are capable business partners and suppliers. To learn more about how CMMI can help your organization elevate performance, visit CMMIinstitute.com.

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com